Bausch Health Companies Inc. (NYSE: BHC) said its revenues for the second quarter edged up 1% to $2.15 billion, in line with the average analysts’ estimate. Revenues at its biggest Bausch + Lomb/International segment was flat year-over-year.
GAAP net loss narrowed to 49 cents per share, compared to $2.49 per share in the same period last year, driven by lower interest expense and lower loss on extinguishment of debt. On an adjusted basis, net income missed street view by a cent.
BHC stock gained 2.9% following the earnings announcement. BHC shares have been trading sidewise in the trailing 12 months, and is currently up 3%.
The Canadian pharma giant also raised its revenue and its adjusted EBITDA guidance range for the full-year. It currently expects full-year revenues of $8.40 billion – $8.60 billion, compared to the earlier estimate of $8.35 billion – $8.55 billion.
Outlook on adjusted EBITDA was raised to $3.425 billion – $3.575 billion, from the prior estimate of $3.40 billion – $3.55 billion.
CEO Joseph C. Papa said, “Looking to the second half of 2019, we expect a number of catalysts to drive growth across our core business segments as we continue to reduce debt, increase R&D and further grow our newly launched products.”
After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many
Lennar (LEN) believes that despite near-term challenges, the long-term prospects for housing remain strong
Shares of Lennar Corporation (NYSE: LEN) were down 3% on Monday. The stock has dropped 36% year-to-date and 25% over the past 12 months. The homebuilder delivered mixed results for
Shares of KB Home (NYSE: KBH) were up slightly on Friday. The stock has dropped 40% year-to-date and 35% over the past 12 months. The company delivered mixed results for